Please login to the form below
venture capital
This page shows the latest venture capital news and features for those working in and with pharma, biotech and healthcare.
Gyroscope advances gene therapy platform, merges with Orbit
Syncona's Chris Hollowood. Both companies have been backed by Syncona, a venture capital firm focused on life sciences, including a host of UK-based cell and gene therapy firms.
Latest news
-
Voice biomarker device could diagnose depression, heart disease
The financing round was led by M Ventures (the corporate venture capital arm of Merck KGaA, Darmstadt, Germany), with MP Healthcare Venture Management (the corporate venture capital arm of Mitsubishi Tanabe
-
UK biotech Artios Pharma appoints new medical director
in financial backing last August from a host of independent and pharma-backed venture capital funds.
-
Investments show UK biotech still booming despite Brexit
They say the figures suggest that the sector could break the fundraising record set in 2018, when over £1bn of venture capital was raised. . ... Only Iceland raised more venture capital than the UK, due to £231m raised there by a single company,
-
Grey Wolf secures £10m Series A to ‘illuminate’ tumour cells
He confirms that the company hopes to deliver a clinical candidate within the next three years, and thanks to its recent funding from venture capital firms Andera Partners and Canaan, it ... Thierry Hercend, Venture Partner at Andera Partners, said:
-
UK biotech booms in 2018, despite Brexit worries
venture capital funding that went to the sector across Europe, according to a BioIndustry Association (BIA) report. ... The £2.2bn tally is around £1bn more than the amount raised in 2017 and included £1.1bn in venture funding with deals tending to be
More from news
Approximately 1 fully matching, plus 90 partially matching documents found.
Latest Intelligence
-
Brain power: fresh approaches to Alzheimer’s drug discovery
The venture capital approach to dementia research. The Dementia Discovery Fund is a venture capital fund focused on discovering and developing novel therapies for dementia, first set up in October 2015. ... The global consortium aims to take a biotech
-
AI UK – one year on
States. 1. Published in January 2018, our work found that despite great excitement for healthcare AI in tech and venture capital communities, patients themselves were at best only cautiously embracing the
-
Biopharma's Future: Made in China
Money flowing into Europe. Meanwhile, just as multinationals are increasing their investments in China, there is also a huge amount of investment capital flowing out of China, and into European and ... Venture capital funds based in China invested $1.4bn
-
30 Women Leaders in UK Healthcare (part 2)
19. Kate Bingham, Managing Partner, SV Life Sciences. Kate is one of the best-known faces in UK biotech venture capital, which plays an increasingly important part in the life sciences
-
When is it time to rebrand?
Four critical success factors for brand initiatives are:. Readiness - Companies need to be ready to invest their focus, capital and human resources. ... We need to raise venture capital. We’ve had a crisis and we need to reset.
More from intelligence
Approximately 0 fully matching, plus 16 partially matching documents found.
Latest appointments
-
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO
He has held roles for Hovione Capital, a life science focused venture capital company, and has served on several life science company boards.
-
Marinomed appoints CFO, Robin Brown is named chair of Medicines Discovery Catapult and more
Brown succeeds Graham Boulnois, the group’s founding chairman, and brings experience of academic research, biotech, big pharma and US venture capital to the role. ... capital and financial markets. “His deep industry expertise, experience in oncology
-
Prevail Therapeutics adds to its board of directors
Before his time at NPS, Nader was a venture partner at Care Capital and he also previously served on the North America leadership team of Aventis and its predecessor companies, holding
-
Dr Martin Rothman joins Sofinnova Partners
He becomes the firm’s venture partner. Life Science-focused European venture capital firm, Sofinnova Partners, has appointed Dr Martin Rothman as venture partner. ... Rothman said: “I am thrilled to join Sofinnova Partners’ team as venture partner.
-
Neurocentrx appoints two members to the board
His career history has seen him work in private equity and venture capital and he has been president of the ABPI.
More from appointments
Approximately 0 fully matching, plus 21 partially matching documents found.
Latest from PMHub
-
Random42 Attending Jefferies 2018 London Healthcare Conference
This global gathering of leading healthcare executives and institutional, private equity and venture capital investors will address near- and long-term investment opportunities and discuss the mechanisms driving global healthcare.
-
Random42 appoints Bill Collis as Chairman
He has vast experience in venture capital and private equity funding, intellectual property licensing, mergers and acquisitions and accessing international markets.
-
Managing value: Why early asset development and commercialization is important
Investors understand that it’s a gamble, but like every gambler they want the best odds. The figures really are staggering: there are companies with assets in development that have capital ... But while venture capital investors are pumping many
-
Four Communications makes further move into healthcare sector with acquisition of Packer Forbes
About BGF:BGF (Business Growth Fund) is the UK’s most active provider of growth capital to small and mid-sized businesses. ... BGF Ventures is the largest UK dedicated venture capital company for earlier stage technology related businesses.
-
Big Bear Communications
We are a Strategic Marketing Consultancy to the pharmaceuticals / biotech sector and our clients include companies from the sector as well as those from the Venture Capital / Private Equity sector.
More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.
Featured jobs
- Freelance Medical Writer - Healthcare Advertising - London
-
Employment Type:. Type of Job:. Region:. Salary:. 250 to 330 per day
- Account Manager / Senior Account Manager - Healthcare Advertisin...
-
Excellent Remuneration
-
Senior Medical Writer
-
Salary TBC
- Project Manager - Medical Communications – South Wales
-
Excellent Remuneration Package
- Project Manager - Digital Healthcare - London
-
Excellent Remuneration Package
-
Senior Medical Writer
-
Competitive salary and benefits
- Senior Account Director/ Associate Director- Pharma and Life Sci...
-
Competitive salary and benefits
- Editor – Medical Education Agency – Bucks
-
Salary TBC
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
-
Director – Healthcare PR
-
Salary TBC
- Account Director – London based Medical Communications Agency
-
Excellent Remuneration Package
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Experienced / Senior Account Director - Publications - London
-
Up to £80, 000 plus great benefits
- Senior / Principal Medical Writer - MedComms - Home Based / Vari...
-
Excellent Remuneration Packages
-
Account Director, Medical Education
-
Salary TBC
- Senior Account Manager- Pharma and Life Scienes
-
Competitive salary and benefits
Subscribe to our email news alerts
- With Spiriva under pressure, Boehringer moves to bolster pipeline
- Genfit claims FDA breakthrough status for liver disease drug
- Mereo’s shareholders back OncoMed takeover
- Lucid Group announces the appointment of new CFO
- From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
- Q&A: Niels Lund
PMHub
Weber Shandwick
At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...
Latest intelligence
- From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
- How pharma is progressing their commitment in patient engagement...
- Cuttsy+Cuttsy awarded CPD Platinum by the IPA
- Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
- Breaking Bad
- Six behaviours separate the good brand teams from the bad...
Quick links
Infographics
